99 related articles for article (PubMed ID: 11597794)
1. Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer.
Sasaki H; Yukiue H; Kobayashi Y; Tanahashi M; Moriyama S; Nakashima Y; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Cancer Lett; 2001 Nov; 173(2):187-92. PubMed ID: 11597794
[TBL] [Abstract][Full Text] [Related]
2. CDC25B: relationship with angiogenesis and prognosis in non-small cell lung carcinoma.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Fontanini G
Hum Pathol; 2007 Oct; 38(10):1563-8. PubMed ID: 17651784
[TBL] [Abstract][Full Text] [Related]
3. Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer.
Sasaki H; Yukiue H; Kobayashi Y; Moriyama S; Nakashima Y; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Int J Cancer; 2001 Nov; 95(6):375-7. PubMed ID: 11668520
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
Wu W; Fan YH; Kemp BL; Walsh G; Mao L
Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma.
Takemasa I; Yamamoto H; Sekimoto M; Ohue M; Noura S; Miyake Y; Matsumoto T; Aihara T; Tomita N; Tamaki Y; Sakita I; Kikkawa N; Matsuura N; Shiozaki H; Monden M
Cancer Res; 2000 Jun; 60(11):3043-50. PubMed ID: 10850455
[TBL] [Abstract][Full Text] [Related]
6. MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer.
Ko JL; Cheng YW; Chang SL; Su JM; Chen CY; Lee H
Int J Cancer; 2000 May; 89(3):265-70. PubMed ID: 10861503
[TBL] [Abstract][Full Text] [Related]
7. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
[TBL] [Abstract][Full Text] [Related]
9. Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis.
Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Nakamura Y; Kakudo K; Miyauchi A
Cancer Lett; 2005 Nov; 229(2):291-7. PubMed ID: 16095809
[TBL] [Abstract][Full Text] [Related]
10. Expression of the cdc25B mRNA correlated with that of N-myc in neuroblastoma.
Sato Y; Sasaki H; Kondo S; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Jpn J Clin Oncol; 2001 Sep; 31(9):428-31. PubMed ID: 11689596
[TBL] [Abstract][Full Text] [Related]
11. Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.
Sasaki H; Lo KM; Chen LB; Auclair D; Nakashima Y; Moriyama S; Fukai I; Tam C; Loda M; Fujii Y
Jpn J Cancer Res; 2001 Aug; 92(8):869-73. PubMed ID: 11509119
[TBL] [Abstract][Full Text] [Related]
12. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
13. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
16. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
20. Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer.
Sasaki H; Moriyama S; Yukiue H; Kobayashi Y; Nakashima Y; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Lung Cancer; 2001 Oct; 34(1):53-7. PubMed ID: 11557113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
